Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytosis, Langerhans-Cell × cobimetinib × 90 days × Clear all

Sponsor

Conditions

Melanoma 4 Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Skin Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma, Follicular 1

Interventions

X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 Magnetic Resonance Spectroscopy 3 Biopsy 3 trametinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 dabrafenib 2 ulixertinib 1 tipifarnib 1 tazemetostat 1 selpercatinib 1 palbociclib 1 olaparib 1 larotrectinib 1 etoposide phosphate 1 Vemurafenib 1 Sirolimus 1 LY3023414 1 Genetic Testing 1 Etoposide 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡